Mineralys Therapeutics, Inc. Quarterly Assets in USD from Q4 2022 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Mineralys Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2022 to Q2 2025.
Mineralys Therapeutics, Inc. Assets for the quarter ending June 30, 2025 was $336M, a 5.41% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$336M	+$17.2M	+5.41%	Jun 30, 2025	10-Q	2025-08-12
Q1 2025	$355M	+$7.69M	+2.22%	Mar 31, 2025	10-Q	2025-05-12
Q4 2024	$206M	-$45.7M	-18.2%	Dec 31, 2024	10-Q	2025-08-12
Q3 2024	$268M	-$9.3M	-3.35%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$318M	+$27.3M	+9.37%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$347M	+$40.8M	+13.3%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$252M	+$137M	+120%	Dec 31, 2023	10-K	2025-02-12
Q3 2023	$278M			Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$291M			Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$306M			Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$114M			Dec 31, 2022	10-K	2024-03-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.